Global Growth & Differentiation Factor 8 Market Research Report 2023

Publication ID:

PB503239979

Publication Date:

March 23, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Growth & Differentiation Factor 8 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Growth & Differentiation Factor 8 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Growth & Differentiation Factor 8 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Growth & Differentiation Factor 8 in Becker Muscular Dystrophy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Growth & Differentiation Factor 8 include Acceleron Pharma, Inc., Atara Biotherapeutics, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Milo Biotechnology LLC, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sarepta Therapeutics, Inc. and Scholar Rock, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Growth & Differentiation Factor 8, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Growth & Differentiation Factor 8.
The Growth & Differentiation Factor 8 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Growth & Differentiation Factor 8 market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Growth & Differentiation Factor 8 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Acceleron Pharma, Inc.
Atara Biotherapeutics, Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Milo Biotechnology LLC
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc.
Scholar Rock, Inc.
Segment by Type
OSX-200
SRK-015
ACE-2494
ACE-2798
BMS-986089
Others
Segment by Application
Becker Muscular Dystrophy
Fibrosis
Myelofibrosis
Sickle Cell Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Growth & Differentiation Factor 8 companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Growth & Differentiation Factor 8 Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 OSX-200
1.2.3 SRK-015
1.2.4 ACE-2494
1.2.5 ACE-2798
1.2.6 BMS-986089
1.2.7 Others
1.3 Market by Application
1.3.1 Global Growth & Differentiation Factor 8 Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Becker Muscular Dystrophy
1.3.3 Fibrosis
1.3.4 Myelofibrosis
1.3.5 Sickle Cell Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Growth & Differentiation Factor 8 Market Perspective (2018-2029)
2.2 Growth & Differentiation Factor 8 Growth Trends by Region
2.2.1 Global Growth & Differentiation Factor 8 Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Growth & Differentiation Factor 8 Historic Market Size by Region (2018-2023)
2.2.3 Growth & Differentiation Factor 8 Forecasted Market Size by Region (2024-2029)
2.3 Growth & Differentiation Factor 8 Market Dynamics
2.3.1 Growth & Differentiation Factor 8 Industry Trends
2.3.2 Growth & Differentiation Factor 8 Market Drivers
2.3.3 Growth & Differentiation Factor 8 Market Challenges
2.3.4 Growth & Differentiation Factor 8 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Growth & Differentiation Factor 8 Players by Revenue
3.1.1 Global Top Growth & Differentiation Factor 8 Players by Revenue (2018-2023)
3.1.2 Global Growth & Differentiation Factor 8 Revenue Market Share by Players (2018-2023)
3.2 Global Growth & Differentiation Factor 8 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Growth & Differentiation Factor 8 Revenue
3.4 Global Growth & Differentiation Factor 8 Market Concentration Ratio
3.4.1 Global Growth & Differentiation Factor 8 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Growth & Differentiation Factor 8 Revenue in 2022
3.5 Growth & Differentiation Factor 8 Key Players Head office and Area Served
3.6 Key Players Growth & Differentiation Factor 8 Product Solution and Service
3.7 Date of Enter into Growth & Differentiation Factor 8 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Growth & Differentiation Factor 8 Breakdown Data by Type
4.1 Global Growth & Differentiation Factor 8 Historic Market Size by Type (2018-2023)
4.2 Global Growth & Differentiation Factor 8 Forecasted Market Size by Type (2024-2029)
5 Growth & Differentiation Factor 8 Breakdown Data by Application
5.1 Global Growth & Differentiation Factor 8 Historic Market Size by Application (2018-2023)
5.2 Global Growth & Differentiation Factor 8 Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Growth & Differentiation Factor 8 Market Size (2018-2029)
6.2 North America Growth & Differentiation Factor 8 Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Growth & Differentiation Factor 8 Market Size by Country (2018-2023)
6.4 North America Growth & Differentiation Factor 8 Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Growth & Differentiation Factor 8 Market Size (2018-2029)
7.2 Europe Growth & Differentiation Factor 8 Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Growth & Differentiation Factor 8 Market Size by Country (2018-2023)
7.4 Europe Growth & Differentiation Factor 8 Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Growth & Differentiation Factor 8 Market Size (2018-2029)
8.2 Asia-Pacific Growth & Differentiation Factor 8 Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Growth & Differentiation Factor 8 Market Size by Region (2018-2023)
8.4 Asia-Pacific Growth & Differentiation Factor 8 Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Growth & Differentiation Factor 8 Market Size (2018-2029)
9.2 Latin America Growth & Differentiation Factor 8 Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Growth & Differentiation Factor 8 Market Size by Country (2018-2023)
9.4 Latin America Growth & Differentiation Factor 8 Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Growth & Differentiation Factor 8 Market Size (2018-2029)
10.2 Middle East & Africa Growth & Differentiation Factor 8 Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Growth & Differentiation Factor 8 Market Size by Country (2018-2023)
10.4 Middle East & Africa Growth & Differentiation Factor 8 Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acceleron Pharma, Inc.
11.1.1 Acceleron Pharma, Inc. Company Detail
11.1.2 Acceleron Pharma, Inc. Business Overview
11.1.3 Acceleron Pharma, Inc. Growth & Differentiation Factor 8 Introduction
11.1.4 Acceleron Pharma, Inc. Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.1.5 Acceleron Pharma, Inc. Recent Development
11.2 Atara Biotherapeutics, Inc.
11.2.1 Atara Biotherapeutics, Inc. Company Detail
11.2.2 Atara Biotherapeutics, Inc. Business Overview
11.2.3 Atara Biotherapeutics, Inc. Growth & Differentiation Factor 8 Introduction
11.2.4 Atara Biotherapeutics, Inc. Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.2.5 Atara Biotherapeutics, Inc. Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Detail
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Growth & Differentiation Factor 8 Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Detail
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Growth & Differentiation Factor 8 Introduction
11.4.4 Eli Lilly and Company Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.4.5 Eli Lilly and Company Recent Development
11.5 Milo Biotechnology LLC
11.5.1 Milo Biotechnology LLC Company Detail
11.5.2 Milo Biotechnology LLC Business Overview
11.5.3 Milo Biotechnology LLC Growth & Differentiation Factor 8 Introduction
11.5.4 Milo Biotechnology LLC Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.5.5 Milo Biotechnology LLC Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Detail
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Growth & Differentiation Factor 8 Introduction
11.6.4 Pfizer Inc. Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.6.5 Pfizer Inc. Recent Development
11.7 Regeneron Pharmaceuticals, Inc.
11.7.1 Regeneron Pharmaceuticals, Inc. Company Detail
11.7.2 Regeneron Pharmaceuticals, Inc. Business Overview
11.7.3 Regeneron Pharmaceuticals, Inc. Growth & Differentiation Factor 8 Introduction
11.7.4 Regeneron Pharmaceuticals, Inc. Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
11.8 Sarepta Therapeutics, Inc.
11.8.1 Sarepta Therapeutics, Inc. Company Detail
11.8.2 Sarepta Therapeutics, Inc. Business Overview
11.8.3 Sarepta Therapeutics, Inc. Growth & Differentiation Factor 8 Introduction
11.8.4 Sarepta Therapeutics, Inc. Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.8.5 Sarepta Therapeutics, Inc. Recent Development
11.9 Scholar Rock, Inc.
11.9.1 Scholar Rock, Inc. Company Detail
11.9.2 Scholar Rock, Inc. Business Overview
11.9.3 Scholar Rock, Inc. Growth & Differentiation Factor 8 Introduction
11.9.4 Scholar Rock, Inc. Revenue in Growth & Differentiation Factor 8 Business (2018-2023)
11.9.5 Scholar Rock, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Acceleron Pharma, Inc.
Atara Biotherapeutics, Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Milo Biotechnology LLC
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc.
Scholar Rock, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂